INCY - Company ID 0000879169
The table below shows INCYTE CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.27B | $1.37B | $1.22B | $1.05B | $1.14B | $1.04B |
| Cost of revenue | $104.52M | $99.00M | $78.77M | $73.19M | $85.99M | $76.63M |
| Gross profit | - | - | - | - | - | - |
| R&D | $515.90M | $506.58M | $494.92M | $437.28M | $573.17M | $1.14B |
INCYTE CORP reported annual revenue of $5.14B for fiscal year 2025. That is up 21.2% from $4.24B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.11B (FY 2016) to $5.14B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $328.09M |
| $329.08M |
| $331.02M |
| $325.69M |
| $309.21M |
| $305.98M |
| Operating income | $301.12M | $443.52M | $530.31M | $205.17M | $146.09M | -$478.13M |
| Income tax | $40.27M | $58.14M | $153.01M | $75.99M | $50.07M | $54.82M |
| Net income | $303.33M | $424.17M | $405.00M | $158.20M | $106.46M | -$444.60M |
| EPS (diluted) | $1.47 | $2.11 | $2.04 | $0.80 | $0.54 | -$2.04 |